Gottlieb Wants His US FDA Team To Stay Together After He Departs
Executive Summary
Outgoing US FDA Commissioner Scott Gottlieb doesn't want a staff shakeup at the agency upon his departure. A look at near-term leadership strategies. Also, the wait time for confirmed commissioners has been trending down.
You may also be interested in...
US FDA Again Looks Outside Generic Drugs Office For New Director
Sally Choe, who has been working in the Office of Translational Sciences, will take over for Kathleen Uhl in March.
Commissioner Succession Plan? Abernethy As Gottlieb’s Number Two Offers One Option
Gottlieb’s choice of Amy Abernethy as US FDA principal deputy could set her up to succeed him, should the need arise. CDER’s Cavazzoni will fill the post on temporary basis, elevating her profile within agency.
US FDA's Ostroff, Twice An Acting Commissioner, Retiring Next Year
A former Walmart executive will replace the deputy commissioner for foods and veterinary medicine, who spent nearly 15 months total as acting commissioner.